Search

everythinglearnresearchcommunity

for

Search:↓

Control inflammation and prevent further hair loss in folliculitis decalvans using medications and therapies.

Many hair diseases, including those caused by medications and psychological issues, can lead to hair loss and require proper treatment and specialist care.

Some people with primary cicatricial alopecia also have inflammatory bowel disease, suggesting a possible connection.

Examining scalp biopsies in different ways helps better diagnose hair loss types.

Early diagnosis and aggressive treatment are crucial for Cicatricial Alopecia, and treatment effectiveness varies among patients.

Early detection and treatment of folliculitis keloidalis can prevent disease progression.

The study found that hair transplant complications are rare, with swelling being the most common issue.

Primary cicatricial alopecia causes permanent hair loss by destroying hair follicles, and its exact cause is unknown.

AI can effectively detect hair and scalp disorders from images.

GLP-1 agonists may help treat certain skin conditions.

Intraoperative corticosteroids reduce swelling, and early care lowers folliculitis risk in hair transplant donor sites.

Early treatment of Folliculitis Decalvans in children can improve inflammation and partially regrow hair.

The microbiome may be linked to hair loss and could be a target for new treatments.

New treatments and diagnostic methods for various animal skin conditions showed promising results.

Different hair disorders have specific treatments and outcomes, with some resolving on their own and others requiring medication or emotional support.

Hair regrowth was seen in 83% of children with alopecia, immune system plays a role in the condition, and various treatments showed effectiveness for hair and nail disorders.

Different races and genders have unique skin and hair issues, requiring specialized care and more research for effective treatment.

The study found that Temporal Triangular Alopecia often starts in early childhood, mainly affects the left side of the scalp, and has no effective treatment except surgery.

Pubic hair transplantation can help women with little to no pubic hair, using scalp hair for a natural look and requires careful aftercare.

A baby was diagnosed with IFAP syndrome due to a new genetic mutation, showing severe skin and developmental issues.

High CCL11 levels may indicate poor response to baricitinib in severe alopecia areata.

New medications could improve treatment for severe alopecia areata in Australia.

Combining platelet-rich plasma and minoxidil can effectively regrow hair in severe alopecia areata cases.

Both individual and combined treatments of tofacitinib and corticosteroids can help regrow hair in moderate-to-severe alopecia areata, but ongoing treatment may be necessary.

A 9-year-old girl with a healthy immune system was successfully treated for a severe fungal scalp infection caused by Microsporum audouinii.

Tofacitinib is more effective than methotrexate for treating moderate-to-severe alopecia areata.

Blocking EGFR can lead to hair loss due to inflammation and stem cell damage.

Anti-EGFR therapy can cause skin issues, but FGF7 treatment might help.

Malassezia infection may cause refractory acne, and antifungal treatments can help.

New mutations in MBTPS2 reduce its function and cause IFAP syndrome with unusual symptoms.